Evidence map›Paper›PMID 15618223›Full record

ArticleThe Journal of biological chemistry2005

Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells.

Samson Amos, Patrick M Martin, Gregory A Polar, Sarah J Parsons, Isa M Hussaini

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cellular functions regulated by phosphorylation of EGFR on Tyr845.International journal of molecular sciences · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Samson AmosDepartment of Pathology, University of Virginia Health System, Charlottesville 22908, USA. sa7h@virginia.edu
Patrick M Martin
Gregory A Polar
Sarah J Parsons
Isa M Hussaini
University of Virginia Health System · US

Funding

Role of PKCeta in Regulating Astrocytoma Invasive GrowthR01CA090851 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LOPES, MARIA-BEATRIZ S. · 2002 to 2011
$2.1M
Role of LRP in Astrocytoma MigrationR01NS035122 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUSSAINI, ISA M · 2003 to 2007
$1.6M
REGULATION OF LRP EXPRESSION AND FUNCTION IN THE CNSR29NS035122 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUSSAINI, ISA M · 1997 to 2001
$262k
NCI NIH HHS CA90851NCI NIH HHS R01 CA090851NINDS NIH HHS NS35122NINDS NIH HHS R01 NS035122NINDS NIH HHS R29 NS035122
6 · The paper itself

Abstract

Both the epidermal growth factor receptor (EGFR) and protein kinase C (PKC) play important roles in glioblastoma invasive growth; however, the interaction between the EGFR and PKC is not well characterized in glioblastomas. Treatment with EGF stimulated global phosphorylation of the EGFR at Tyr(845), Tyr(992), Tyr(1068), and Tyr(1045) in glioblastoma cell lines (U-1242 MG and U-87 MG). Interestingly, phorbol 12-myristate 13-acetate (PMA) stimulated phosphorylation of the EGFR only at Tyr(1068) in the two glioblastoma cell lines. Phosphorylation of the EGFR at Tyr(1068) was not detected in normal human astrocytes treated with the phorbol ester. PMA-induced phosphorylation of the EGFR at Tyr(1068) was blocked by bisindolylmaleimide (BIM), a PKC inhibitor, and rottlerin, a PKCdelta-specific inhibitor. In contrast, Go 6976, an inhibitor of classical PKC isozymes, had no effect on PMA-induced EGFR phosphorylation. Furthermore, gene silencing with PKCdelta small interfering RNA (siRNA), siRNA against c-Src, and mutant c-Src(S12C/S48A) and treatment with a c-Src inhibitor (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine) abrogated PMA-induced EGFR phosphorylation at Tyr(1068). PMA induced serine/threonine phosphorylation of Src, which was blocked by both BIM and rottlerin. Inhibition of the EGFR with AG 1478 did not significantly alter PMA-induced EGFR Tyr(1068) phosphorylation, but completely blocked EGF-induced phosphorylation of the EGFR. The effects of PMA on MAPK phosphorylation and glioblastoma cell proliferation were reduced by BIM, rottlerin, the MEK inhibitor U0126, and PKCdelta and c-Src siRNAs. Taken together, our data demonstrate that PMA transactivates the EGFR and increases cell proliferation by activating the PKCdelta/c-Src pathway in glioblastomas.

Indexed as

Transcriptional ActivationAcetophenonesAstrocytesBenzopyransBlotting, WesternButadienesCell Line, TumorCell ProliferationEnzyme InhibitorsErbB ReceptorsGlioblastomaHumansImmunoprecipitationModels, BiologicalNitrilesPhosphorylationAcetophenonesBenzopyransButadienesEnzyme InhibitorsErbB ReceptorsNitrilesPRKCD protein, humanProtein IsoformsProtein Kinase CProtein Kinase C-deltaRNA, Small Interferingrottlerinsrc-Family KinasesTetradecanoylphorbol AcetateThymidineTyrosineU 0126

Identifiers

PMID15618223
PMCPMC1351089
OpenAlexW2010897402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.